CHLPE's inaugural Director from 2015–2023, Colleen M. Flood is recognized as one of Canada’s leading scholars in the area of health law and policy, and is an accomplished leader, author, and commentator. She has made a significant impact on the policies and areas of research informing health services and care delivery sectors and public health, both in Canada and around the world. Her comparative research has been incorporated into national and global debates over privatization, health system design, accountability, and governance, pandemic preparedness and response and the role of courts in defending rights in health care. Her latest work focuses on the governance of health-related artificial intelligence.

Adam R. Houston is a Canadian health & human rights advocate, specializing in access to medicines and the role of law in the response to infectious disease. He has worked with organizations across Canada and around the world on a wide range of issues, including global COVID-19 vaccine (in)equity, reconciling disparate human rights approaches towards HIV and tuberculosis, and United Nations accountability for the Haitian cholera epidemic. By day, he is the Medical Policy & Advocacy Advisor for Médecins sans frontières/Doctors Without Borders (MSF) Canada.

Jason Nickerson is the Humanitarian Representative to Canada for Doctors Without Borders/Médecins Sans Frontières (MSF), based in Ottawa. Jason is appointed as a Clinical Scientist at the Bruyère Research Institute in Ottawa and as an Adjunct Professor of Common Law at the University of Ottawa. He leads MSF’s humanitarian diplomacy in Canada and provides advice on humanitarian operations, medical advocacy and policy, and access to medicines to MSF’s operations in more than 70 countries affected by crises. Jason has over 10 years’ clinical experience as a respiratory therapist working in adult critical care and anesthesia and has worked extensively in global public health response in Canada and internationally during armed conflicts, disease epidemics, and sudden onset disasters. He is widely quoted in international news outlets on a variety of global health and health policy issues including COVID-19, access to pain medicines for safe anesthesia and palliative care, access to affordable medicines, science policy, and humanitarian assistance in natural disasters, armed conflicts, refugee crises, and disease epidemics such as Ebola.

Dr. Kumanan Wilson is a specialist in General Internal Medicine at The Ottawa Hospital; Chief Executive Officer/Chief Scientific Officer, Bruyère Research Institute; Vice President Research & Academic, Bruyère Continuing Care; Chief Scientific Officer, CANImmunize Inc.; and Faculty of Medicine Clinical Research Chair in Digital Health Innovation, University of Ottawa. He is the co-founder of CANImmunize Inc., a science-based technology company spun out from The Ottawa Hospital in 2019. To help Canadians keep track of their vaccinations, the team developed CANImmunize, a pan-Canadian digital immunization tracking system available as a mobile app and through a web portal. Dr. Wilson’s research focuses on digital health, immunization, pandemic preparedness and public health policy and innovation. His research on immunization has explored social media’s impact on vaccine hesitancy, evaluation of vaccine safety using health services data and vaccine policy, including advocating for vaccine injury compensation. Other research interests include blood safety and newborn screening, health ethics, law and policy.

Marco Zenone is an assistant professor of health science communication at the Faculty of Health Sciences, University of Ottawa. He completed his Ph.D. in public health and policy at the London School of Hygiene and Tropical Medicine, University of London. He then completed his postdoctoral training as a Banting Postdoctoral Fellow at the School of Public Policy and Global Affairs, University of British Columbia.

Marco's research group studies the spread, impact, and political economy of health misinformation and disinformation, examining how patients and the public are misled about treatments, disease causes, and health risks, and how health topics are portrayed across digital platforms. It focuses on the commercial determinants of health, including how profit-driven systems and platform structures amplify misleading or harmful content. It emphasizes moving away from blaming individuals and toward creating accountable systems that prevent, mitigate, and respond to disinformation.